Clinical Trials Logo
  1. Home
  2. Other
  3. NCT06354556

Effect of Verapamil Tablets on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects

Obstructive Hypertrophic Cardiomyopathy Clinical Trial

Official title:
Effect of Verapamil on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects: a Single Center, Open, Single Arm, and Fixed Sequence Study

Clinical Trial Summary

The purpose of this phase Ⅰ study is to evaluate the effect of oral verapamil tablets on the pharmacokinetics of HRS-1893 in healthy subjects.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06354556
Study type Interventional
Source Shandong Suncadia Medicine Co., Ltd.
Contact Meng Fu
Phone +86 0518-82342973
Email meng.fu@hengrui.com
Status Not yet recruiting
Phase Phase 1
Start date April 15, 2024
Completion date May 30, 2024
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06023186 - Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM
Completed NCT05726799 - Use of Cryoenergy to Faciltate Myectomy in Hypertrophic Obstructive Cardiomyopathy: Comparison With the Classical Approach
Active, not recruiting NCT03723655 - A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM Phase 2/Phase 3
Completed NCT04603521 - Patients' Long-Term Survival of Obstructive Hypertrophic Cardiomyopathy (HCM)
Active, not recruiting NCT06211595 - Feasibility Study of the DragonFire for Hypertrophic Obstructive Cardiomyopathy N/A
Recruiting NCT06116968 - An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM Phase 3
Completed NCT03470545 - Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Phase 3
Recruiting NCT05879523 - A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy Phase 1
Not yet recruiting NCT06146660 - A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Recruiting NCT05771987 - Permanent Pacing for Drug-refractory Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy. N/A
Active, not recruiting NCT05174416 - A Study to Evaluate the Efficacy and Safety of Mavacamten in Chinese Adults With Symptomatic Obstructive HCM Phase 3
Not yet recruiting NCT06224621 - Percutaneous Endocardial Septal Radiofrequency Ablation in Obstructive Hypertrophic Cardiomyopathy N/A
Completed NCT01631006 - Effects of Continous Positive Airway Pressure (CPAP) in Hypertrophic Cardiomyopathy N/A
Not yet recruiting NCT06368037 - Feasibility Study of the DragonFire for Hypertrophic Obstructive Cardiomyopathy N/A
Recruiting NCT05489705 - A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive HCM)
Completed NCT04783766 - Safety, Tolerability and Pharmacokinetics Study of CK-3773274 Phase 1